Environmental epigenetic modifications and reprogramming-recalcitrant genes

Stem Cell Research

Volumn 4, Issue 3, 2010, Pages 157-164

  Sakurada, Kazuhiro ^a  

^a SONY COMPUTER SCIENCE LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUCOCORTICOID RECEPTOR; HISTONE; TRANSCRIPTION FACTOR NANOG;

CELL THERAPY; CHROMATIN; CHRONIC DISEASE; DISEASE PREDISPOSITION; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE FUNCTION; GENETIC EPIGENESIS; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PATHOGENESIS; PHENOTYPIC VARIATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW;

ALKALINE PHOSPHATASE; EPIGENESIS, GENETIC; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING;

ANIMALIA;

EID: 77952288039     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.01.001     Document Type: Review

References (69)

1. Allegrucci C., et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum. Mol. Genet. 16 (2007) 1253-1268
2. Amariglio N., et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. e1000029 (2009) 6
3. Boiani M., et al. Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev. 16 (2002) 1209-1219
4. Bortvin A., et al. Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development 130 (2003) 1673-1680
5. Bromer J.G., Wu J., Zhou Y., and Taylor H.S. Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 150 (2009) 3376-3382
6. Butler D. Crossing the valley of death. Nature 453 (2008) 840-842
7. Camargo F.D., Green R., Capetanaki Y., Jackson K.A., and Goodell M.A. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat. Med. 9 (2003) 1520-1527
8. Chin M.H., et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5 (2009) 111-123
9. Chu M.W., et al. Lack of increases in methylation at three CpG rich genomic loci in non-mitotic adult tissues during aging. BMC Med. Genet. 8 (2007) 50
10. Deng J., et al. Targeted bisulfate sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27 (2009) 353-360
11. Dimos J.T., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321 (2008) 1218-1221
12. Ebert A.D., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457 (2009) 277-280
13. Eckhardt F., et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 12 (2006) 1378-1385
14. Eminli S., et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 41 (2009) 968-976
15. Eot-Houllier G., et al. Histone deacetylase inhibitors and genomic instability. Cancer Lett. 274 (2009) 169-176
16. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 10604-10609
17. Gluckman P.D., and Hanson M.A. Living with the past: evolution, development, and patterns of disease. Science 305 (2004) 1733-1736
18. Goldberg A.D., Allis C.D., and Bernstein E. Epigenetics: A landscape takes shape. Cell 128 (2007) 635-638
19. Groth A., Rocha W., Verreault A., and Almouzni G. Chromatin challenges during DNA replication and repair. Cell 128 (2007) 721-733
20. Gurdon J.B., and Melton D.A. Nuclear reprogramming in cells. Science 322 (2008) 1811-1815
21. Hellwig J., et al. Pre-and postonatal oral toxicity of vinclozolin in Wistar and Long-Evans rats. Regul. Toxicol. Pharmacol. 32 (2000) 42-50
22. Hitchins M.P., et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N. Engl. J. Med. 356 (2007) 697-705
23. Holliday R., and Pugh J.E. DNA modification mechanisms and gene activity during development. Science 187 (1975) 226-232
24. Hong H., et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460 (2009) 1132-1135
25. Huangfu D., et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26 (2008) 795-797
26. Huxley R., et al. Is birth weight a risk factor for ischemic heart disease in later life?. Am. J. Clin. Nutr. 85 (2007) 1244-1250
27. Jirtle R.L., and Skinner M.L. Environmental epigenomics and disease susceptibility. Nat. Rev., Genet. 8 (2007) 253-262
28. Kishigami S., and Wakayama T. Somatic cell nuclear transfer in the mouse. Methods Mol. Biol. 518 (2009) 207-218
29. Klip H., Verloop J., van Gool J.D., Koster M.E., Burger C.W., and van Leeuwen F.E. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 359 (2002) 1102-1107
30. Kohda T., et al. Variation in gene expression and aberrantly regulated chromosome regions in cloned mice. Biol. Reprod. 73 (2005) 1302-1311
31. Li H., et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460 (2009) 1149-1153
32. Lister R., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462 (2009) 315-322
33. Lowry W.E., et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 2883-2888
34. Masaki H., et al. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res. 1 (2008) 105-115
35. Mattick J.S., et al. RNA regulation of epigenetic processes. BioEssays 31 (2009) 51-59
36. Meissner A., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454 (2008) 766-770
37. Molofsky A.V., et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425 (2003) 962-967
38. Ng R.K., and Gurdon J.B. Epigenetic memory of active gene transcription is inherited through somatic cell nuclear transfer. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1957-1962
39. Ogonuki N., et al. Early death of mice cloned from somatic cells. Nat. Genet. 30 (2002) 253-254
40. Park I.H., et al. Disease-specific induced pluripotent stem cells. Cell 134 (2008) 877-886
41. Park I.H., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
42. Park I.K., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
43. Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet. 22 (2006) 347-350
44. Rando T.A. Stem cells, ageing and the quest for immortality. Nature 441 (2006) 1080-1086
45. Raya A., et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460 (2009) 53-59
46. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447 (2007) 425-432
47. Rideout W.M., Eggan K., and Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science 293 (2001) 1093-1098
48. Riggs A.D. X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 14 (1975) 9-25
49. Rountree C.B., et al. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells 25 (2007) 2419-2429
50. Sadikovic B., Andrews J., Carter D., Robinson J., and Rodenhiser D.I. Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells. J. Biol. Chem. 283 (2008) 4051-4060
51. Sakurada K., McDonald F.M., and Shimada F. Regenerative Medicine and stem cell based drug discovery. Angew. Chem. Int. Ed. 47 (2008) 5718-5738
52. Silva J., et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6 (2008) e253
53. Soldner F., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136 (2009) 964-977
54. Suzuki K., et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9 (2006) 199-207
55. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
56. Tamashiro K.L., et al. Cloned mice have an obese phenotype not transmitted to their offspring. Nat. Med. 8 (2002) 262-267
57. Tanaka S., et al. Placentomegaly in cloned mouse concepti caused by expansion of the spongiotrophoblast layer. Biol. Reprod. 65 (2001) 1813-1821
58. Tsankova N.M., et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neruosci. 9 (2006) 519-525
59. Waddington C.H. The epigenotype. Endeavour 1 (1942) 18-20
60. Waterland R.A., and Michels K.B. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 27 (2007) 363-388
61. Weaver I.C., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004) 847-854
62. Wong A.H.C., Gottesman I.I., and Petronis A. Phenotypic differences in genetically identical organisms: the epigenetic perspective. Hum. Mol. Genet. 14 (2005) R11-18
63. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 460 (2009) 49-52
64. Yongson N.A., and Whitelaw E. Transgenerational epigenetic effects. Annu. Rev. Genomics Hum. Genet. 9 (2008) 233-257
65. Yoshida Y., Takahashi K., Okita K., Ichisaka T., and Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5 (2009) 237-241
66. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
67. Zeng W., et al. Transcript profile of CD4+and CD8+T cells from the bone marrow of acquired aplastic anemia patients. Exp. Hematol. 32 (2004) 806-814
68. Zhang C.L., et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
69. Zhao Y., Glesne D., and Huberman E.A. human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2426-2431